BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25473840)

  • 1. Dynamic scenario of membrane binding process of kalata b1.
    Nawae W; Hannongbua S; Ruengjitchatchawalya M
    PLoS One; 2014; 9(12):e114473. PubMed ID: 25473840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-Silico Template Selection of In-Vitro Evolved Kalata B1 of Oldenlandia Affinis for Scaffolding Peptide-Based Drug Design.
    Senthilkumar B; Kumar P; Rajasekaran R
    J Cell Biochem; 2016 Jan; 117(1):66-73. PubMed ID: 26052694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics exploration of poration and leaking caused by Kalata B1 in HIV-infected cell membrane compared to host and HIV membranes.
    Nawae W; Hannongbua S; Ruengjitchatchawalya M
    Sci Rep; 2017 Jun; 7(1):3638. PubMed ID: 28620219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.
    Plan MR; Rosengren KJ; Sando L; Daly NL; Craik DJ
    Biopolymers; 2010; 94(5):647-58. PubMed ID: 20564013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the membrane disruption mechanism of kalata B1 via coarse-grained molecular dynamics simulations.
    Nawae W; Hannongbua S; Ruengjitchatchawalya M
    Sci Rep; 2014 Feb; 4():3933. PubMed ID: 24492660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cyclotide Kalata B1 protein with model cellular membranes of varied electrostatics.
    Gupta R; Kumari J; Pati S; Singh S; Mishra M; Ghosh SK
    Int J Biol Macromol; 2021 Nov; 191():852-860. PubMed ID: 34592223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulations support a preference of cyclotide kalata B1 for phosphatidylethanolamine phospholipids.
    Roseli RB; Huang YH; Henriques ST; Kaas Q; Craik DJ
    Biochim Biophys Acta Biomembr; 2024 Mar; 1866(3):184268. PubMed ID: 38191035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of conserved Glu residue on cyclotide stability and activity: a structural and functional study of kalata B12, a naturally occurring Glu to Asp mutant.
    Wang CK; Clark RJ; Harvey PJ; Rosengren KJ; Cemazar M; Craik DJ
    Biochemistry; 2011 May; 50(19):4077-86. PubMed ID: 21466163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The self-association of the cyclotide kalata B2 in solution is guided by hydrophobic interactions.
    Rosengren KJ; Daly NL; Harvey PJ; Craik DJ
    Biopolymers; 2013 Sep; 100(5):453-60. PubMed ID: 23893463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformation and mode of membrane interaction in cyclotides. Spatial structure of kalata B1 bound to a dodecylphosphocholine micelle.
    Shenkarev ZO; Nadezhdin KD; Sobol VA; Sobol AG; Skjeldal L; Arseniev AS
    FEBS J; 2006 Jun; 273(12):2658-72. PubMed ID: 16817894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.
    Henriques ST; Huang YH; Rosengren KJ; Franquelim HG; Carvalho FA; Johnson A; Sonza S; Tachedjian G; Castanho MA; Daly NL; Craik DJ
    J Biol Chem; 2011 Jul; 286(27):24231-41. PubMed ID: 21576247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminal pro-domain of the kalata B1 cyclotide precursor is intrinsically unstructured.
    Daly NL; Gunasekera S; Clark RJ; Lin F; Wade JD; Anderson MA; Craik DJ
    Biopolymers; 2016 Nov; 106(6):825-833. PubMed ID: 27564841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motif.
    Daly NL; Clark RJ; Plan MR; Craik DJ
    Biochem J; 2006 Feb; 393(Pt 3):619-26. PubMed ID: 16207177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orientation and Location of the Cyclotide Kalata B1 in Lipid Bilayers Revealed by Solid-State NMR.
    Grage SL; Sani MA; Cheneval O; Henriques ST; Schalck C; Heinzmann R; Mylne JS; Mykhailiuk PK; Afonin S; Komarov IV; Separovic F; Craik DJ; Ulrich AS
    Biophys J; 2017 Feb; 112(4):630-642. PubMed ID: 28256223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional characterization of chimeric cyclotides from the Möbius and trypsin inhibitor subfamilies.
    Abdul Ghani H; Henriques ST; Huang YH; Swedberg JE; Schroeder CI; Craik DJ
    Biopolymers; 2017 Jan; 108(1):. PubMed ID: 27487329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of cyclotides and variations in cyclotide expression in Oldenlandia affinis suspension cultures.
    Seydel P; Gruber CW; Craik DJ; Dörnenburg H
    Appl Microbiol Biotechnol; 2007 Nov; 77(2):275-84. PubMed ID: 17786427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclotides insert into lipid bilayers to form membrane pores and destabilize the membrane through hydrophobic and phosphoethanolamine-specific interactions.
    Wang CK; Wacklin HP; Craik DJ
    J Biol Chem; 2012 Dec; 287(52):43884-98. PubMed ID: 23129773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclotides are a component of the innate defense of Oldenlandia affinis.
    Mylne JS; Wang CK; van der Weerden NL; Craik DJ
    Biopolymers; 2010; 94(5):635-46. PubMed ID: 20564018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Design of Hypothetical New Peptides Based on a Cyclotide Scaffold as HIV gp120 Inhibitor.
    Sangphukieo A; Nawae W; Laomettachit T; Supasitthimethee U; Ruengjitchatchawalya M
    PLoS One; 2015; 10(11):e0139562. PubMed ID: 26517259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1.
    Eliasen R; Daly NL; Wulff BS; Andresen TL; Conde-Frieboes KW; Craik DJ
    J Biol Chem; 2012 Nov; 287(48):40493-501. PubMed ID: 23012369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.